The improved therapeutic effects of adefovir dipivoxil in patients with HBeAg-negative chronic hepatitis B offset against its increased cost compared to lamivudine

被引：1
作者：
Buti, M.
Casado, M. A.
Calleja, J. L.
Salmeron, J.
Guilar, J. A.
Rueda, M.
Esteban, R.
机构：
[1] Hosp Gen Valle Hebron, Dept Internal Med, Liver Unit, Barcelona, Spain
[2] Pharmacoecon & Outcomes Res, Madrid, Spain
[3] Hosp Puerto Hierro, Madrid, Spain
[4] Hosp Clin San Cecilio, Granada, Spain
[5] Hosp Virgen Del Rocio, Seville, Spain
[6] Gilead Sci Inc, Madrid, Spain
来源：
JOURNAL OF HEPATOLOGY | 2006年 / 44卷
关键词：
D O I：
10.1016/S0168-8278(06)80485-X
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
485
引用
收藏
页码：S180 / S180
页数：1
相关论文
共 50 条
[21]   The comparison of adefovir dipivoxil or combination with lamivudine in patients with lamivudine resistant chronic hepatitis B [J].
Ayaz, Celal ;
Celen, M. Kemal ;
Geyik, M. Faruk ;
Bayan, Kadim ;
Dal, Tuba ;
Altindis, Mustafa .
JOURNAL OF CLINICAL VIROLOGY, 2015, 70 :S118-S119
[22]   HBeAg-negative chronic hepatitis B: Cost-effectiveness of peginterferon alfa-2a compared to lamivudine in Taiwan [J].
Veenstra, David L. ;
Sullivan, Sean D. ;
Lai, Ming-Yang ;
Lee, Chuan-Mo ;
Tsai, Chia-Ming ;
Patel, Kavita K. .
VALUE IN HEALTH, 2008, 11 (02) :131-138
[23]   Extended treatment with lamivudine and adefovir dipivoxil in chronic hepatitis B patients with lamivudine resistance [J].
Robert P. Perrillo ;
Hie-Won Hann ;
Eugene Schiff ;
David Mutimer ;
Bernard Willems ;
Nancy Leung ;
William M. Lee ;
Susan Dixon ;
Mary Woessner ;
Carol L. Brosgart ;
Lynn D. Condreay ;
Stephen D. Gardner .
Hepatology International, 2011, 5 :654-663
[24]   HBSAG SEROCOVERSION UNDER LAMIVUDINE IN HBEAG-NEGATIVE CHRONIC HEPATITIS B [J].
Seven, Gulseren ;
Idilman, Ramazan ;
Bozkus, Yusuf ;
Cinar, Kubilay ;
Kabacam, Gokhan ;
Yakut, Mustafa ;
Bozdayi, A. Mithat ;
Yurdaydin, Cihan .
HEPATOLOGY, 2010, 52 (04) :545A-546A
[25]   Cost-effectiveness simulation analysis of tenofovir disoproxil fumarate (tenofovir), lamivudine, adefovir dipivoxil (adefovir) and entecavir of HBeAg negative (-) patients with chronic hepatitis-B (CHB) in Spain [J].
Deniz, B. ;
Buti, M. ;
Brosa, M. ;
Casado, M. A. ;
Rueda, M. ;
Everhard, F. ;
Esteban, R. .
JOURNAL OF HEPATOLOGY, 2008, 48 :S209-S209
[26]   Lamivudine treatment in HBeAg-negative chronic hepatitis B patients with low level viraemia [J].
Bozkaya, H ;
Yurdaydin, C ;
Idilman, R ;
Tüzün, A ;
Cinar, K ;
Erkan, Ö ;
Bozdayi, AM ;
Erden, E ;
Uzun, Y ;
Cetinkaya, H ;
Uzunalimoglu, Ö .
ANTIVIRAL THERAPY, 2005, 10 (02) :319-325
[27]   Clinical and virological response to adefovir dipovixil for lamivudine-resistant HBeAg-negative hepatitis B [J].
Scotto, G ;
Palumbo, E ;
Fazio, V ;
Tartaglia, A ;
Saracino, A ;
Angarano, G .
NEW MICROBIOLOGICA, 2005, 28 (03) :193-197
[28]   Adefovir alone or combination with lamivudine in patients with lamivudine-resistance chronic HBeAg-negative hepatitis B. A non randomized multicenter controlled study [J].
Manolakopoulos, S ;
Bethanis, S ;
Koutsounas, S ;
Goulis, J ;
Saveriadis, A ;
Xristias, E ;
Christidou, A ;
Pavlidis, C ;
Toubanakis, C ;
Vlachogiannakos, J ;
Triantos, C ;
Avgerinos, A ;
Tzourmakliotis, D .
HEPATOLOGY, 2005, 42 (04) :592A-593A
[29]   Mutations Associated With the Therapeutic Efficacy of Adefovir Dipivoxil Added to Lamivudine in Patients Resistant to Lamivudine With Type B Chronic Hepatitis [J].
Ohkawa, Kazuyoshi ;
Takehara, Tetsuo ;
Kato, Michio ;
Kanada, Aimi ;
Deguchi, Matsuo ;
Kagita, Masanori ;
Hikita, Hayato ;
Sasakawa, Akira ;
Kohga, Keisuke ;
Uemura, Akio ;
Sakamori, Ryotaro ;
Yamaguchi, Shinjiro ;
Miyagi, Takuya ;
Ishida, Hisashi ;
Tatsumi, Tomohide ;
Hayashi, Norio .
JOURNAL OF MEDICAL VIROLOGY, 2009, 81 (05) :798-806
[30]   Rescue treatment with adefovir dipivoxil in lamivudine resistant patients with chronic hepatitis B [J].
Vigano, M ;
Lampertico, P ;
Iavarone, M ;
Lunghi, G ;
Colucci, G ;
Del Ninno, E ;
Colombo, M .
JOURNAL OF HEPATOLOGY, 2004, 40 :132-133
12345